SCHEMBL20967458

SCHEMBL20967458

Cc1cc(F)cc2ccc(F)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.46
CYP2A6 P11509 3/20 0.46
TYMS P04818 1/20 0.39
BACE1 P56817 1/20 0.38
KIF11 P52732 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
AR P10275 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
KCNH2 Q12809 1/20 0.36
ACHE P22303 2/20 0.36
CASP3 P42574 1/20 0.36
AHR P35869 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MPO P05164 1/20 0.35
CYP19A1 P11511 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20967457 0.83 CYP1A2 (0.42) CYP1A2CYP2A6BACE1KIF11KEAP1
SCHEMBL24448635 0.83 ESR1 (0.39) CYP1A2CYP2A6TYMSKDM4EMPO
SCHEMBL14596470 0.79 CYP1A2 (0.45) CYP1A2CYP2A6BACE1ALDH1A1HPGD
SCHEMBL19919255 0.78 CYP1A2 (0.38) CYP1A2CYP2A6ALDH1A1
SCHEMBL3275947 0.77 CYP1A2 (0.63) CYP1A2CYP2A6TYMSALDH1A1HPGD
SCHEMBL30205860 0.77 CYP1A2 (0.63) CYP1A2CYP2A6TYMSALDH1A1HPGD
SCHEMBL15724649 0.77 CYP1A2 (0.43) CYP1A2CYP2A6TYMSBACE1KIF11
SCHEMBL5249792 0.76 CYP1A2 (0.64) CYP1A2CYP2A6BACE1ALDH1A1HPGD
SCHEMBL20356015 0.75 CYP1A2 (0.50) CYP1A2CYP2A6TYMSBACE1NFE2L2
SCHEMBL811004 0.75 CYP1A2 (0.56) CYP1A2CYP2A6BACE1SLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11251376-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-02-15 US disclosed
US-20190131535-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11251376-B2 Heterocyclic compound and organic light-emitting device including the same LAGE3, DDT, AOC2 CYP1A2 30/4885CYP2A6 897/4885TYMS 1242/4885
US-20190131535-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, DDT, AOC2 CYP1A2 30/4885CYP2A6 897/4885TYMS 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.